Beatriz Cicuéndez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Beatriz Cicuéndez has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Cintia Folgueira
Organ Crosstalk in Metabolic Diseases Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain
4 shared publications - Guadalupe Sabio
Organ Crosstalk in Metabolic Diseases Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain
4 shared publications - Alfonso Mora
Organ Crosstalk in Metabolic Diseases Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain
3 shared publications - Andreas Daiber
University Medical Center Mainz, Johannes Gutenberg University, Mainz, Germany
2 shared publications Elena Rodríguez
Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
2 shared publications- Javier Pérez-García
Organ Crosstalk in Metabolic Diseases Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain
2 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1476
Altered ROCK1/ROCK2 Expression and RhoA/ROCK-Related Transcriptional Signatures Across Human and Experimental Models of Alcohol Exposure
Chronic and acute alcohol exposure induce tissue-specific pathophysiological changes across multiple organ systems. Rho-associated coiled-coil kinases (ROCK1 and ROCK2) are key effectors of RhoA GTPases and participate in diverse biological processes, including the regulation of cytoskeletal dynamics, inflammation, fibrosis, apoptosis and redox homeostasis; however, their contribution to alcohol-related disorders remains incompletely understood. In this study, we evaluated ROCK1 and ROCK2 expression by qPCR and performed a cross-tissue, multi-model analysis integrating peripheral blood (PB) from human cohorts with alcohol use disorder (AUD) and acute alcohol consumption (AAC), in vitro cultures of ethanol-treated human peripheral blood mononuclear cells (PBMCs) and mouse astrocytes, and animal models. Additionally, pathway-level transcriptional profiling was conducted to assess upstream activators, core Rho/ROCK components, and downstream inflammatory, fibrotic, and apoptotic signatures in PB from AUD patients, liver tissue from the NIAAA mouse model, and astrocyte cultures. Apoptosis-related transcriptional changes were assessed using the BCL2/BAX mRNA ratio. Ethanol exposure was associated with increased expression of ROCK isoforms across several models and tissues. Alterations in ROCK1/ROCK2 expression and in RhoA/ROCK-related transcriptional signatures were accompanied by tissue-specific inflammatory, fibrotic, and apoptosis-related transcriptional changes. These findings suggest that ethanol exposure is associated with alterations in ROCK1/ROCK2 expression and RhoA/ROCK-related transcriptional signatures across different experimental settings. They also support further investigation of the functional relevance of this pathway and its potential implications as a biomarker and therapeutic target in alcohol-related disorders.
- 15 November 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1476
Open AccessAltered ROCK1/ROCK2 Expression and RhoA/ROCK-Related Transcriptional Signatures Across Human and Experimental Models of Alcohol Exposure
Chronic and acute alcohol exposure induce tissue-specific pathophysiological changes across multiple organ systems. Rho-associated coiled-coil kinases (ROCK1 and ROCK2) are key effectors of RhoA GTPases and participate in diverse biological processes, including the regulation of cytoskeletal dynamics, inflammation, fibrosis, apoptosis and redox homeostasis; however, their contribution to alcohol-related disorders remains incompletely understood. In this study, we evaluated ROCK1 and ROCK2 expression by qPCR and performed a cross-tissue, multi-model analysis integrating peripheral blood (PB) from human cohorts with alcohol use disorder (AUD) and acute alcohol consumption (AAC), in vitro cultures of ethanol-treated human peripheral blood mononuclear cells (PBMCs) and mouse astrocytes, and animal models. Additionally, pathway-level transcriptional profiling was conducted to assess upstream activators, core Rho/ROCK components, and downstream inflammatory, fibrotic, and apoptotic signatures in PB from AUD patients, liver tissue from the NIAAA mouse model, and astrocyte cultures. Apoptosis-related transcriptional changes were assessed using the BCL2/BAX mRNA ratio. Ethanol exposure was associated with increased expression of ROCK isoforms across several models and tissues. Alterations in ROCK1/ROCK2 expression and in RhoA/ROCK-related transcriptional signatures were accompanied by tissue-specific inflammatory, fibrotic, and apoptosis-related transcriptional changes. These findings suggest that ethanol exposure is associated with alterations in ROCK1/ROCK2 expression and RhoA/ROCK-related transcriptional signatures across different experimental settings. They also support further investigation of the functional relevance of this pathway and its potential implications as a biomarker and therapeutic target in alcohol-related disorders.
- Open Access
The aging modulator miR-29 is essential for adult cardiomyocyte function
Aging is the main risk factor for cardiovascular diseases, underscoring the need to identify the molecular regulators that sustain cardiac function during aging. The microRNA miR-29 is a well-established aging-associated regulator as its expression increases with age, and its overexpression promotes premature aging. Here, we define the cardiomyocyte-autonomous role of miR-29 in the adult heart by generating an inducible, cardiomyocyte-specific miR-29-deficient mouse model (Heart-iKO). We show that Heart-iKO mice develop dilated cardiomyopathy (DCM) with reduced ejection fraction that ultimately leads to premature death. Mechanistically, Heart-iKO cardiomyocytes exhibit alterations in mitochondrial structure and function. Transcriptomic profiling of bulk heart tissue and isolated cardiomyocytes revealed a consistent downregulation of genes involved in oxidative phosphorylation and the electron transport chain. We further observed a similar pattern of mitochondrial impairment in miR-29-deficient human cardiomyocytes derived from induced pluripotent stem cells (CM-iPSCs). Together, these findings highlight the context-dependent role of miR-29 in cardiac physiology and aging: although its upregulation promotes premature aging, its basal expression is required to maintain mitochondrial homeostasis and prevent heart failure in the adult myocardium.
Open AccessThe aging modulator miR-29 is essential for adult cardiomyocyte function
Aging is the main risk factor for cardiovascular diseases, underscoring the need to identify the molecular regulators that sustain cardiac function during aging. The microRNA miR-29 is a well-established aging-associated regulator as its expression increases with age, and its overexpression promotes premature aging. Here, we define the cardiomyocyte-autonomous role of miR-29 in the adult heart by generating an inducible, cardiomyocyte-specific miR-29-deficient mouse model (Heart-iKO). We show that Heart-iKO mice develop dilated cardiomyopathy (DCM) with reduced ejection fraction that ultimately leads to premature death. Mechanistically, Heart-iKO cardiomyocytes exhibit alterations in mitochondrial structure and function. Transcriptomic profiling of bulk heart tissue and isolated cardiomyocytes revealed a consistent downregulation of genes involved in oxidative phosphorylation and the electron transport chain. We further observed a similar pattern of mitochondrial impairment in miR-29-deficient human cardiomyocytes derived from induced pluripotent stem cells (CM-iPSCs). Together, these findings highlight the context-dependent role of miR-29 in cardiac physiology and aging: although its upregulation promotes premature aging, its basal expression is required to maintain mitochondrial homeostasis and prevent heart failure in the adult myocardium.
- Open Access
- 13 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Absence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis
Obesity poses a global health challenge, demanding a deeper understanding of adipose tissue (AT) and its mitochondria. This study describes the role of the mitochondrial protein Methylation-controlled J protein (MCJ/DnaJC15) in orchestrating brown adipose tissue (BAT) thermogenesis. Here we show how MCJ expression decreases during obesity, as evident in human and mouse adipose tissue samples. MCJKO mice, even without UCP1, a fundamental thermogenic protein, exhibit elevated BAT thermogenesis. Electron microscopy unveils changes in mitochondrial morphology resembling BAT activation. Proteomic analysis confirms these findings and suggests involvement of the eIF2α mediated stress response. The pivotal role of eIF2α is scrutinized by in vivo CRISPR deletion of eIF2α in MCJKO mice, abrogating thermogenesis. These findings uncover the importance of MCJ as a regulator of BAT thermogenesis, presenting it as a promising target for obesity therapy.
- 13 January 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-16
Open AccessAbsence of MCJ/DnaJC15 promotes brown adipose tissue thermogenesis
Obesity poses a global health challenge, demanding a deeper understanding of adipose tissue (AT) and its mitochondria. This study describes the role of the mitochondrial protein Methylation-controlled J protein (MCJ/DnaJC15) in orchestrating brown adipose tissue (BAT) thermogenesis. Here we show how MCJ expression decreases during obesity, as evident in human and mouse adipose tissue samples. MCJKO mice, even without UCP1, a fundamental thermogenic protein, exhibit elevated BAT thermogenesis. Electron microscopy unveils changes in mitochondrial morphology resembling BAT activation. Proteomic analysis confirms these findings and suggests involvement of the eIF2α mediated stress response. The pivotal role of eIF2α is scrutinized by in vivo CRISPR deletion of eIF2α in MCJKO mice, abrogating thermogenesis. These findings uncover the importance of MCJ as a regulator of BAT thermogenesis, presenting it as a promising target for obesity therapy.
- Open Access
A Combination of a Dopamine Receptor 2 Agonist and a Kappa Opioid Receptor Antagonist Synergistically Reduces Weight in Diet-Induced Obese Rodents
As the global obesity rate increases, so does the urgency to find effective anti-obesity drugs. In the search for therapeutic targets, central nervous system (CNS) mechanisms engaged in the regulation of energy expenditure and food intake, such as the opioid and dopamine systems, are crucial. In this study, we examined the effect on body weight of two drugs: bromocriptine (BC), a D2R receptor agonist, and PF-04455242, a selective κ opioid receptor (KOR) antagonist. Using diet-induced obese (DIO) rats, we aimed to ascertain whether the administration of BC and PF-04455242, independently or in combination, could enhance body weight loss. Furthermore, the present work demonstrates that the peripheral coadministration of BC and PF-04455242 enhances the reduction of weight in DIO rats and leads to a decrease in adiposity in a food-intake-independent manner. These effects were based on heightened energy expenditure, particularly through the activation of brown adipose tissue (BAT) thermogenesis. Overall, our findings indicate that the combination of BC and PF-04455242 effectively induces body weight loss through increased energy expenditure by increasing thermogenic activity and highlight the importance of the combined use of drugs to combat obesity.
Open AccessA Combination of a Dopamine Receptor 2 Agonist and a Kappa Opioid Receptor Antagonist Synergistically Reduces Weight in Diet-Induced Obese Rodents
As the global obesity rate increases, so does the urgency to find effective anti-obesity drugs. In the search for therapeutic targets, central nervous system (CNS) mechanisms engaged in the regulation of energy expenditure and food intake, such as the opioid and dopamine systems, are crucial. In this study, we examined the effect on body weight of two drugs: bromocriptine (BC), a D2R receptor agonist, and PF-04455242, a selective κ opioid receptor (KOR) antagonist. Using diet-induced obese (DIO) rats, we aimed to ascertain whether the administration of BC and PF-04455242, independently or in combination, could enhance body weight loss. Furthermore, the present work demonstrates that the peripheral coadministration of BC and PF-04455242 enhances the reduction of weight in DIO rats and leads to a decrease in adiposity in a food-intake-independent manner. These effects were based on heightened energy expenditure, particularly through the activation of brown adipose tissue (BAT) thermogenesis. Overall, our findings indicate that the combination of BC and PF-04455242 effectively induces body weight loss through increased energy expenditure by increasing thermogenic activity and highlight the importance of the combined use of drugs to combat obesity.
- Open Access
- 19 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (3) , eadk6524
MCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension
Pulmonary hypertension (PH) can affect both pulmonary arterial tree and cardiac function, often leading to right heart failure and death. Despite the urgency, the lack of understanding has limited the development of effective cardiac therapeutic strategies. Our research reveals that MCJ modulates mitochondrial response to chronic hypoxia. MCJ levels elevate under hypoxic conditions, as in lungs of patients affected by COPD, mice exposed to hypoxia, and myocardium from pigs subjected to right ventricular (RV) overload. The absence of MCJ preserves RV function, safeguarding against both cardiac and lung remodeling induced by chronic hypoxia. Cardiac-specific silencing is enough to protect against cardiac dysfunction despite the adverse pulmonary remodeling. Mechanistically, the absence of MCJ triggers a protective preconditioning state mediated by the ROS/mTOR/HIF-1α axis. As a result, it preserves RV systolic function following hypoxia exposure. These discoveries provide a potential avenue to alleviate chronic hypoxia-induced PH, highlighting MCJ as a promising target against this condition.
- 19 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (3) , eadk6524
Open AccessMCJ: A mitochondrial target for cardiac intervention in pulmonary hypertension
Pulmonary hypertension (PH) can affect both pulmonary arterial tree and cardiac function, often leading to right heart failure and death. Despite the urgency, the lack of understanding has limited the development of effective cardiac therapeutic strategies. Our research reveals that MCJ modulates mitochondrial response to chronic hypoxia. MCJ levels elevate under hypoxic conditions, as in lungs of patients affected by COPD, mice exposed to hypoxia, and myocardium from pigs subjected to right ventricular (RV) overload. The absence of MCJ preserves RV function, safeguarding against both cardiac and lung remodeling induced by chronic hypoxia. Cardiac-specific silencing is enough to protect against cardiac dysfunction despite the adverse pulmonary remodeling. Mechanistically, the absence of MCJ triggers a protective preconditioning state mediated by the ROS/mTOR/HIF-1α axis. As a result, it preserves RV systolic function following hypoxia exposure. These discoveries provide a potential avenue to alleviate chronic hypoxia-induced PH, highlighting MCJ as a promising target against this condition.